share_log

Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $28

Benzinga ·  Oct 16, 2023 10:25

Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target from $37 to $28.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment